AskBio
Manufacturing · North Carolina, United States · 501-1,000 Employees
View Company Info for Free
Overview
Headquarters
20 Tw Alexander Dr Ste 110, Durham, Nort...Phone Number
(919) 561-6210Website
www.askbio.comRevenue
$19.4 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About AskBio
AskBio, is a fully integrated molecular medicine and technology company with operations around the globe. AskBio remains dedicated to the advancement of transformative gene therapeutics, pioneering research and development, groundbreaking synthetic biology, and scalable cGMP manufacturing. Its robust pipeline includes gene therapy candidates at various clinical stages for neuromuscular, central nervous system, metabolic, and cardiovascular diseases. AskBio also has a portfolio of over 775 molecular and genetic medicine patents and an expansive library of capsids and promoters. Global headquarters are in RTP, NC, and European headquarters in Edinburgh. AskBios AAV research centers are in Philadelphia, PA; Columbus, OH; and Paris. Modern clinical, commercial, and synthetic DNA manufacturing facilities are in San Sebastian, Spain. AskBio is a wholly owned, independently operated subsidiary of Bayer.Explore more
AskBio Org Chart
AV
Global Senior VP, Clinical Development
RB
Operations & Digital Strategy Vice President,...
BB
Vice President, Gmp Quality
AH
Vice President, Manufacturing Science & Techn...
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is AskBio your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if AskBio had a recent Job posting/layoffs
Check out if AskBio is spiking on competitors!
Earning: See what the market has to say on AskBio recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at AskBio
Product Launch: Get notified when AskBio launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
AskBio, which may be a good buyer, showed buying intent in Masked Content Topic
Check if AskBio has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once AskBio has new funding data
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Compare Similar Companies to AskBio
Compare insights from companies similar to AskBio, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$843.9M
1K - 5K
Private
-
2007
MP
Melissa Pickell-MattsonProgram Director, Human Resources & Chief of Staff
Company Profile Activity
Activity Insights
AskBio is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
AskBio is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about AskBio.
AskBio financials insights
Gather financial insights about AskBio, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2004
Grant
$1.6M
2020
Grant
$2.6M
AskBio Tech Stack
A closer look at the technologies used by AskBio
Most Recent Scoops
Project
Laboratory Operations, Medical Research, Clinical Operations
Open Position
Open Position
Open Position
Partnership
Project
Laboratory Operations, Medical Research, Clinical Operations
AskBio News & Media
First Participant Dosed in AskBio Phase 1/Phase 2 Gene Therapy Trial of AB-1009 for Late-Onset Pompe Disease (LOPD)
Durham, N.C., May 11, 2026 (GLOBE NEWSWIRE) -- AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that the first participant has been dosed with investigational gene therapy AB-1009 as part of PROGRESS-GT LOPD, a Phase 1/Phase 2 clinical trial in participants with late-onset Pompe disease (LOPD).AskBio Announces 6 Presentations at American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting
Durham, N.C., May 07, 2026 (GLOBE NEWSWIRE) -- AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, will deliver 6 presentations at the American Society of Gene and Cell Therapy (ASGCT) 29th Annual Meeting, which takes place May 11–15, 2026, in Boston, Massachusetts, USA. The company’s oral and poster presentations will provide updates on important research activities in gene therapy, as well as subsidiary Viralgen’s advancements inAskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease
Berlin, Germany, and Durham, N.C., USA, April 20, 2026 (GLOBE NEWSWIRE) -- Not intended for UK MediaAskBio Announces Completion of Enrollment in Phase 2 Clinical Trial of AB-1002 Investigational Gene Therapy for Heart Failure
Durham, N.C., April 01, 2026 (GLOBE NEWSWIRE) -- AskBio Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, today announced that the randomization of the last participant was completed earlier this year for GenePHIT, its Phase 2 clinical trial of AB-1002, an investigational gene therapy being developed as a potential treatment for heart failure with reduced ejection fraction (HFrEF).
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding AskBio
Sign Up For FreeTo access detailed company insights
AskBio, is a fully integrated molecular medicine and technology company with operations around the globe. AskBio remains dedicated to the advancement of transformative gene therapeutics, pioneering research and development, groundbreaking synthetic biology, and scalable cGMP manufacturing. Its robust pipeline includes gene therapy candidates at var... Read More
